Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. IGC Pharma Inc. (IGC) Message Board

420 with CNW — Despite Ongoing Challenges, Calif

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 436
(Total Views: 261)
Posted On: 07/07/2023 5:01:40 PM
Avatar
Posted By: NetworkNewsWire
420 with CNW — Despite Ongoing Challenges, California’s Legal Cannabis Market Remains Huge

Despite facing financial and tax challenges, California’s marijuana industry remains unparalleled as the largest cannabis market globally. According to the recent MJBizFactbook report, the state is projected to generate approximately $5.9 billion in legal medical and recreational cannabis sales in 2023.

To provide perspective, this revenue could sustain the economy of a small island country. For instance, the International Monetary Fund (IMF) estimates that Barbados’s gross domestic product (GDP) will reach $6.1 billion this year. Additionally, the IMF forecasts Fiji’s GDP to be approximately $5.4 billion.

Given California’s colossal cannabis market, its magnitude is not surprising. If California were an independent country, its GDP for 2022, totaling $3.6 trillion, would rank fifth globally, positioned between Germany and India with $4.2 trillion and $3.2 trillion, respectively.

Furthermore, marijuana has become a prominent agricultural product in California, competing with and sometimes surpassing two major crops. In 2022, grape production, renowned for the state’s exceptional wine industry, reached a value of $5.5 billion, followed by almonds at $3.5 billion.

Comparatively, other marijuana markets in the United States pale in comparison to California’s sales. Michigan, the second-largest American marijuana market in terms of sales, is projected to generate only one-half of California’s consumer purchases, amounting to $3.1 billion in combined medical and recreational cannabis sales this year.

Until states with large populations such as New York or Pennsylvania bolster their markets, California is unlikely to face significant competition. This also holds true for countries such as Germany, which have yet to establish legal recreational markets.

While acquiring precise data on international legal cannabis sales is challenging, Canada, arguably the largest legal adult-use market outside the United States, reported recreational sales of just $3.4 billion in 2022.

Meanwhile, a bill to legalize marijuana cafes in California was recently approved by the state’s assembly committee. The measure allows dispensaries to offer noncannabis food and beverages at their locations, subject to local approval. California is also taking steps to broaden the market for marijuana outside of the state. Regulators are asking the attorney general’s office for a formal opinion on whether allowing marijuana commerce across state lines would put California at a heightened risk of federal enforcement action.

The governor approved a statute last year giving him the authority to enter into deals with other legal jurisdictions to import and export marijuana goods. The request for advice from DCC is an important first step that might ultimately result in the law being put into effect.

Companies such as IGC Pharma Inc. (NYSE American: IGC) that are looking to commercialize pharmaceutical-grade medicines from THC will not have to be concerned about laws surrounding interstate commerce in marijuana products because the moment a given formulation gains FDA approval, the makers are free to market it anywhere within the country.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer



(0)
(0)




IGC Pharma Inc. (IGC) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us